Anti-NDUAA/ NDUFA10/ CI-42KD functional antibody

Anti-NDUAA/ NDUFA10/ CI-42KD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NDUFA10/NDUFA10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1493-Ab-1/ GM-Tg-hg-SE1493-Ab-2Anti-Human NDUFA10 monoclonal antibodyHuman
GM-Tg-rg-SE1493-Ab-1/ GM-Tg-rg-SE1493-Ab-2Anti-Rat NDUFA10 monoclonal antibodyRat
GM-Tg-mg-SE1493-Ab-1/ GM-Tg-mg-SE1493-Ab-2Anti-Mouse NDUFA10 monoclonal antibodyMouse
GM-Tg-cynog-SE1493-Ab-1/ GM-Tg-cynog-SE1493-Ab-2Anti-Cynomolgus/ Rhesus macaque NDUFA10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1493-Ab-1/ GM-Tg-felg-SE1493-Ab-2Anti-Feline NDUFA10 monoclonal antibodyFeline
GM-Tg-cang-SE1493-Ab-1/ GM-Tg-cang-SE1493-Ab-2Anti-Canine NDUFA10 monoclonal antibodyCanine
GM-Tg-bovg-SE1493-Ab-1/ GM-Tg-bovg-SE1493-Ab-2Anti-Bovine NDUFA10 monoclonal antibodyBovine
GM-Tg-equg-SE1493-Ab-1/ GM-Tg-equg-SE1493-Ab-2Anti-Equine NDUFA10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1493-Ab-1/ GM-Tg-hg-SE1493-Ab-2; GM-Tg-rg-SE1493-Ab-1/ GM-Tg-rg-SE1493-Ab-2;
GM-Tg-mg-SE1493-Ab-1/ GM-Tg-mg-SE1493-Ab-2; GM-Tg-cynog-SE1493-Ab-1/ GM-Tg-cynog-SE1493-Ab-2;
GM-Tg-felg-SE1493-Ab-1/ GM-Tg-felg-SE1493-Ab-2; GM-Tg-cang-SE1493-Ab-1/ GM-Tg-cang-SE1493-Ab-2;
GM-Tg-bovg-SE1493-Ab-1/ GM-Tg-bovg-SE1493-Ab-2; GM-Tg-equg-SE1493-Ab-1/ GM-Tg-equg-SE1493-Ab-2
Products NameAnti-NDUFA10 monoclonal antibody
Formatmab
Target NameNDUFA10
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NDUFA10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1493-Ag-1Recombinant multi-species NDUAA/ NDUFA10/ CI-42KD protein


    Target information

    Target IDGM-SE1493
    Target NameNDUFA10
    Gene ID4705,67273,678759,697681,608244,101093631,338060,100057698
    Gene Symbol and Synonyms2900053E13Rik,CI-42k,CI-42KD,MC1DN22,NDUFA10,ndufa10l
    Uniprot AccessionO95299,Q561S0,P54713,P34942
    Uniprot Entry NameNDUAA_HUMAN,NDUAA_RAT,NDUAA_CANLF,NDUAA_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000130414
    Target ClassificationN/A

    The target: NDUFA10, gene name: NDUFA10, also named as CI-42KD, CI-42k. The protein encoded by this gene is a component of 42 kDa complex I, the first enzyme complex in the electron transport chain of mitochondria. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. A mutation in this gene was found in an individual with Leigh syndrome. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.